James D Campbell

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea
    James D Campbell
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Entebbe, Uganda
    Clin Infect Dis 54:1204-11. 2012
  2. pmc Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults
    James D Campbell
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA
    Hum Vaccin 7:81-8. 2011
  3. doi request reprint Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda
    Fatu Forna
    Global AIDS Program, National Center for HIV, Hepatitis, STD, and TB Prevention NCHHSTP, CDC, Atlanta, Georgia, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:128-38. 2009
  4. doi request reprint Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV
    James D Campbell
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC Uganda, Entebbe, Uganda
    Am J Prev Med 44:S63-9. 2013
  5. doi request reprint Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
    Jakub K Simon
    Division of Geomedicine, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States
    Vaccine 29:9544-50. 2011

Collaborators

Detail Information

Publications5

  1. doi request reprint HIV-infected ugandan adults taking antiretroviral therapy with CD4 counts >200 cells/μL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea
    James D Campbell
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Entebbe, Uganda
    Clin Infect Dis 54:1204-11. 2012
    ..Many countries recommend that individuals taking antiretroviral therapy (ART) discontinue cotrimoxazole when CD4 counts are >200 cells/μL. However, this practice has not been evaluated in sub-Saharan Africa...
  2. pmc Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults
    James D Campbell
    Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, USA
    Hum Vaccin 7:81-8. 2011
    ..In conclusion, the newly-licensed vaccine was well tolerated and immunologically non-inferior to the established vaccine for all three vaccine strains in the whole population and the elderly...
  3. doi request reprint Hematologic changes associated with Zidovudine following single-drug substitution from stavudine in a home-based AIDS care program in rural Uganda
    Fatu Forna
    Global AIDS Program, National Center for HIV, Hepatitis, STD, and TB Prevention NCHHSTP, CDC, Atlanta, Georgia, USA
    J Int Assoc Physicians AIDS Care (Chic) 8:128-38. 2009
    ..The authors evaluated hematologic changes associated with zidovudine (ZDV) following single-drug substitution from stavudine (D4T) in HIV-infected persons in Uganda...
  4. doi request reprint Antiretroviral prophylaxis for sexual and injection drug use acquisition of HIV
    James D Campbell
    Division of HIV AIDS Prevention, National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC Uganda, Entebbe, Uganda
    Am J Prev Med 44:S63-9. 2013
    ..PrEP is generally safe and effective and may be cost effective in a targeted population. Awareness and interest in PrEP are increasing. PrEP is an important new addition to HIV prevention services, but continued study is warranted...
  5. doi request reprint Safety, tolerability, and immunogenicity of inactivated trivalent seasonal influenza vaccine administered with a needle-free disposable-syringe jet injector
    Jakub K Simon
    Division of Geomedicine, Department of Medicine, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD, United States
    Vaccine 29:9544-50. 2011
    ..In the first study in humans, the newly-US-licensed LectraJet(®) model M3 RA DSJI was compared to N-S...